This project is a randomized clinical trial comparing ulipristal acetate (UPA) 30 mg followed by misoprostol with mifepristone 200mg followed by misoprostol for telemedicine medication abortion in pregnancies less than 77 days’ duration. Using a hybrid effectiveness–implementation framework, which bridges clinical research and real-world practice by evaluating both whether an intervention works and how it ...Read more >

In the US, future access to mifepristone, the gold standard for medication abortion, is increasingly uncertain. Misoprostol alone, the primary alternative, is effective but has lower efficacy and more side effects than the standard mifepristone-misoprostol regimen. Emerging evidence suggests that ulipristal acetate (UPA) plus misoprostol may offer another alternative, but research is needed to evaluate ...Read more >

In 2025, 65% of all clinician-provided abortions were medication abortions, most provided with mifepristone and misoprostol. Increasingly, mifepristone has been under attack. Like mifepristone, Ulipristal Acetate (UPA) is a selective progesterone receptor (PR) modulator with anti-progesterone effects. In the US, UPA is approved as emergency contraception and marketed as “Ella” in a 30 mg dose ...Read more >

I am an assistant professor in the Department of Social and Behavioral Sciences at Yale University School of Public Health. I have expertise in community-engaged research, qualitative methods, adolescent health, and intervention adaptation and implementation. The overall goal of the proposed research is to explore the process of sexual and reproductive health communication between grandparents, ...Read more >

Dr. Anjanique Mariquit Rosete Lu (she/they/siya) is an assistant professor in the Boston Medical Center Ob-Gyn Department, where she specializes in complex family planning and holds a master’s degree in health policy. Dr. Rosete Lu is a physician-researcher devoted to centering historically marginalized populations’ perspectives, developing equitable yet tailored reproductive healthcare, and supporting clinician counseling ...Read more >

Angubeen Khan is an Assistant Professor at the University of Michigan (UM) Dearborn. She earned her Bachelor of Arts in Global Health and Master of Public Health in Health Behavior and Health Education from the University of Michigan Ann Arbor, and her PhD in Community Health Sciences from the UCLA Fielding School of Public Health. ...Read more >

I am a physician-scientist with dual training in pediatrics and child and adolescent psychiatry, and formal training in health services research. My work focuses on improving access to sexual and reproductive health (SRH) care for adolescents, particularly those with psychiatric conditions who face structural barriers to receiving timely and confidential services. My research seeks to ...Read more >

This Changemakers in Family Planning Award supports the development of Subasri Narasimhan, PhD, MPH who serves as the Research Director for the Center on Reproductive Health, Law, and Policy (CRHLP) at the UCLA School of Law. She plans to strengthen the intersections of public health and medicine and of law and policy, by documenting, evaluating, ...Read more >

Erinma Ukoha, MD, MPH is an Assistant Professor in the Department of Obstetrics and Gynecology, and Reproductive Science at the Icahn School of Medicine at Mount Sinai. Dr. Ukoha’s research interests and advocacy work focus on nonpunitive approaches to substance use in pregnancy, decriminalization of pregnancy, and addressing racial inequities in reproductive care through community-led ...Read more >

I am an Assistant Professor in the Department of Maternal and Child Health at the Gillings School of Global Public Health at the University of North Carolina at Chapel Hill. My work sits at the intersection of family planning services, racial disparities in maternal health, and implementation science. My experience conducting contraception services research in ...Read more >